Nukkleus Liabilities And Stockholders Equity Over Time
| NUKKW Stock | 0.03 0.00 0.000003% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Nukkleus Performance and Nukkleus Correlation. Nukkleus |
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. If investors know Nukkleus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nukkleus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share 7.024 | Quarterly Revenue Growth (0.97) | Return On Assets (1.15) | Return On Equity (0.75) |
The market value of Nukkleus is measured differently than its book value, which is the value of Nukkleus that is recorded on the company's balance sheet. Investors also form their own opinion of Nukkleus' value that differs from its market value or its book value, called intrinsic value, which is Nukkleus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nukkleus' market value can be influenced by many factors that don't directly affect Nukkleus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nukkleus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nukkleus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nukkleus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Liabilities And Stockholders Equity Analysis
Compare Nukkleus and related stocks such as Radcom, Microbot Medical, and Weyco Group Liabilities And Stockholders Equity Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RDCM | 37.4 M | 21.3 M | 19 M | 19.6 M | 20.3 M | 20.1 M | 54.6 M | 91.9 M | 89.5 M | 96.4 M | 93.6 M | 91.7 M | 101 M | 107.5 M | 112.9 M |
| MBOT | 17.3 M | 25.2 M | 30.2 M | 41.6 M | 32.4 M | 21.2 M | 3.4 M | 11 M | 6.1 M | 37.1 M | 26.3 M | 16.8 M | 9.5 M | 8.3 M | 7.9 M |
| WEYS | 44.5 M | 273.5 M | 285.3 M | 267.5 M | 277.4 M | 299 M | 268.2 M | 262.8 M | 270 M | 296.9 M | 256.7 M | 277.7 M | 326.6 M | 309.3 M | 184 M |
| MMSI | 1.6 M | 447 M | 705.3 M | 728.3 M | 747.2 M | 778.7 M | 942.8 M | 1.1 B | 1.6 B | 1.8 B | 1.7 B | 1.6 B | 1.7 B | 2.3 B | 2.4 B |
| HPP | 203 M | 1.2 B | 1.6 B | 2.1 B | 2.3 B | 6.3 B | 6.7 B | 6.6 B | 7.1 B | 7.5 B | 8.4 B | 9 B | 9.3 B | 8.3 B | 5.1 B |
| ACCO | 284.3 M | 1.1 B | 2.5 B | 2.4 B | 2.2 B | 2 B | 2.1 B | 2.8 B | 2.8 B | 2.8 B | 3 B | 3.1 B | 2.8 B | 2.6 B | 1.8 B |
| DIT | 23 M | 105.8 M | 106.4 M | 108.7 M | 120.2 M | 112.3 M | 131.8 M | 140 M | 157.7 M | 188 M | 188.4 M | 289.1 M | 363.4 M | 374.1 M | 392.8 M |
| PINS | 1.2 B | 1.2 B | 1.2 B | 1.2 B | 1.2 B | 1.2 B | 1.2 B | 1.2 B | 1.2 B | 2.4 B | 2.6 B | 3.5 B | 3.9 B | 3.6 B | 2.9 B |
Nukkleus and related stocks such as Radcom, Microbot Medical, and Weyco Group Liabilities And Stockholders Equity description
The total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation.My Equities
My Current Equities and Potential Positions
| Nukkleus | NUKKW |
Specialization | Information Technology, Software - Application |
| Location | China |
| Exchange | NASDAQ Exchange |
null 0.0301
Additional Tools for Nukkleus Stock Analysis
When running Nukkleus' price analysis, check to measure Nukkleus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nukkleus is operating at the current time. Most of Nukkleus' value examination focuses on studying past and present price action to predict the probability of Nukkleus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nukkleus' price. Additionally, you may evaluate how the addition of Nukkleus to your portfolios can decrease your overall portfolio volatility.